What do systematic reviews say?

Intervention not reported

• Recombinant human insulin‐like growth factor I (rhIGF‐I) for the treatment of amyotrophic lateral sclerosis/motor… 2012 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 690 participants
  Low